In a filing, Larimar Therapeutics Inc revealed its Director Hamilton Thomas Edward acquired Company’s shares for reported $0.5 million on Feb 16 ’24. In the deal valued at $8.74 per share,57,208 shares were bought. As a result of this transaction, Hamilton Thomas Edward now holds 564,798 shares worth roughly $3.78 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Flynn James E bought 4,290,617 shares, generating $37,499,993 in total proceeds. Upon buying the shares at $8.74, the Director now owns 6,151,406 shares.
Before that, THOMAS FRANK E bought 2,000 shares. Larimar Therapeutics Inc shares valued at $22,000 were divested by the Director at a price of $11.00 per share. As a result of the transaction, THOMAS FRANK E now holds 2,000 shares, worth roughly $13380.0.
Oppenheimer initiated its Larimar Therapeutics Inc [LRMR] rating to an Outperform in a research note published on October 16, 2024; the price target was $26. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in early October with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering LRMR with “Buy” recommendation on October 02, 2024. Robert W. Baird started covering the stock on September 04, 2024. It rated LRMR as “an Outperform”.
Price Performance Review of LRMR
On Friday, Larimar Therapeutics Inc [NASDAQ:LRMR] saw its stock fall -11.62% to $6.69. Over the last five days, the stock has lost -25.00%. Larimar Therapeutics Inc shares have risen nearly 47.03% since the year began. Nevertheless, the stocks have risen 128.33% over the past one year. While a 52-week high of $13.68 was reached on 02/15/24, a 52-week low of $2.49 was recorded on 01/17/24. SMA at 50 days reached $7.38, while 200 days put it at $8.13.
Levels Of Support And Resistance For LRMR Stock
The 24-hour chart illustrates a support level at 6.26, which if violated will result in even more drops to 5.83. On the upside, there is a resistance level at 7.37. A further resistance level may holdings at 8.04. The Relative Strength Index (RSI) on the 14-day chart is 39.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.73, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.01%. Stochastics %K at 18.08% indicates the stock is a buying.
How much short interest is there in Larimar Therapeutics Inc?
A steep rise in short interest was recorded in Larimar Therapeutics Inc stocks on 2024-10-31, dropping by -0.85 million shares to a total of 2.72 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.57 million shares. There was a decline of -31.07%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 03, 2024 when Leerink Partners began covering the stock and recommended ‘”an Outperform”‘ rating along with a $25 price target.
